Citius Pharmaceuticals- Warrants(02/08/2022) Minority Interest

As of the most recent data (June 2026), CTXRW shows a minority interest of $9.3M. That compares with $2.5M in the prior-year period — up 271.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTXRW's minority interest is now $9.3M (was $2.5M) — a 271.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Citius Pharmaceuticals- Warrants(02/08/2022) is outperforming or lagging.

Tracking CTXRW's minority interest over time shows whether Citius Pharmaceuticals- Warrants(02/08/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $9.3M That compares with $2.5M in the prior-year period — up 271.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Citius Pharmaceuticals- Warrants(02/08/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $9.3M) with ownership activity and broader fundamentals.

Citius Pharmaceuticals- Warrants(02/08/2022)'s minority interest is $9.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.